Founded in Doral, United States, BioTissue Holdings Inc. focuses on regenerative wound healing through the application of human birth tissues. The company's mission is to improve patient outcomes by leveraging advanced tissue preservation technologies. BioTissue offers products for ocular and surgical applications, utilizing their proprietary CryoTek® technology to retain the structure and biology of natural tissues, thereby promoting effective regenerative healing.
BioTissue has made significant strides in the field of regenerative medicine, supported by extensive research and development. The company has garnered attention from notable investors and healthcare professionals who recognize the potential of their innovative approach. BioTissue's impact is evident in the improved healing outcomes for patients and the growing adoption of their products by medical practitioners across the United States.
